Trial intelligence / Profile preview

iPSC-derived HSC Transplantation for Beta-Thalassemia

NCT03222453Unknown

Start: Jan 2015
Primary completion: Jun 2016

Overview

Open-label trial in beta thalassemia (2 arms). Primary endpoints: The check of granulocyte transplantation-granulocyte plant living standards at 3 days, The check of granulocyte transplantation-platelet plant living standards at 7 days and 1 more. Status: unknown.

Conditions

beta thalassemia

Beyond the preview

Go deeper on NCT03222453.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03222453.